Inova Schar Heart and Vascular

07/27/2026

What do GLP-1s have to do with heart health? 💓

In our latest podcast, we discuss how these medications can help reduce the risk of heart attack, who may benefit from treatment and why lifestyle changes still matter.

Apple: https://apple.co/4gFy0zU
Spotify: https://bit.ly/4547yIT

07/16/2026

We're excited to share that the outpatient office for Inova Heart and Lung Transplant has relocated to the Inova Center for Personalized Health, across from Inova Fairfax Hospital. 🏥

The relocation includes:
🩺 Outpatient office for consultations and some treatments for advanced heart and advanced lung diseases [5th floor]
💓 Urgent Heart Failure Clinic for established patients experiencing signs of deteriorating health, with same-day or next-day appointments for timely treatment that may help avoid an Emergency Room visit and, in some cases, hospitalization [2nd floor]
🌬️ Pulmonary Diagnostic Services [1st floor]

Inova’s advanced heart disease program: https://bit.ly/3FV4JRz
Inova’s advanced lung disease program: https://bit.ly/4w0zBoo

07/13/2026

Inova Schar Heart and Vascular is proud to celebrate the grand opening of Cardiac PET/CT services at Inova Cardiac Diagnostics – Willow Oaks. 🏥

This next-generation imaging technology enables more precise detection and evaluation of heart disease, helping physicians make more personalized, confident care decisions for each patient.

Thank you to our providers and team members who made this milestone possible. 💙

Learn more: https://bit.ly/4wb46Iv

07/08/2026

While the ⚽️ FIFA World Cup is underway, athletes are taking center stage – and understanding health risks is especially important.

Dr. M. Casey Flanagan, Medical Director at Inova Sports Cardiology, discusses heart attack risks in athletes and how everyone – from amateur players to professional athletes – can stay healthy and protect their hearts. 📽️ https://bit.ly/4wroCUT

Dr. M. Casey Flanagan, Medical Director at Inova Sports Cardiology, discusses heart attack risk for athletes and how everyone from amateur players to World Cup pros can stay healthy.

07/06/2026

💓 What do the latest cholesterol guidelines mean for your heart health? Several leading medical organizations recently updated long-standing guidelines for cholesterol screening and management, including new guidance on healthy cholesterol levels.

Inova cardiologist Dr. Sachin Gandhi and registered dietitian Rachel C. share practical recommendations to help you maintain healthy cholesterol levels.

📽️ Watch: https://bit.ly/4btE5M6

06/29/2026

Inova Schar Heart and Vascular has performed 100 renal denervation procedures. This places our program among the top 5 volume programs in the U.S. offering this innovative, minimally invasive, catheter-based treatment for patients with hard-to-treat high blood pressure. 💓✨

Patients have demonstrated significant reductions in blood pressure at 2–3 months follow-up, along with improvements in quality of life and reduced reliance on medications.

Congratulations to the team on this incredible milestone. 👏

06/26/2026

Atrial fibrillation (AFib) is the most common heart rhythm disorder, affecting more than 10 million people in the U.S. AFib can lead to blood clots, stroke, heart failure and other serious heart-related complications, making early diagnosis and treatment critical. 💓

Inova electrophysiologist Dr. Elizabeth Held discusses risk factors, symptoms and new treatment options available at Inova that are improving the safety and success of care.

📽️ Watch the webinar: https://vimeo.com/1197456922

06/25/2026

Inova's Advanced Lung Disease team showed up in full force at the Pulmonary Hypertension Association's Greater Washington, DC O2 Breathe Walk to support people living with pulmonary hypertension (PH) and their caregivers! 💜 👟

Our team, "PHast, PHurious and PHabulous," was the #1 top fundraising team, raising 153.2% of our goal 💪 – supporting educational resources and researchers working to find a cure for PH.

05/28/2026

Dr. Steven Nathan, Schar Chair of Advanced Lung Disease and Lung Transplant at Inova and chair of the Steering Committee for the global TETON program, presented the TETON-1 study findings at the 2026 American Thoracic Society (ATS) International Conference in May. The study was simultaneously published in The New England Journal of Medicine, with Dr. Nathan serving as first author.

The study showed that inhaled treprostinil (Tyvaso) helped preserve lung function and reduced the risk of clinical worsening in patients with idiopathic pulmonary fibrosis (IPF), a serious progressive lung disease that causes permanent scarring of the lungs – bringing the drug one step closer to regulatory approval for this use.

Dr. Christopher King, Associate Medical Director of the Advanced Lung Disease Program at Inova Fairfax Hospital, served as Inova's site principal investigator. Inova enrolled the highest number of participants in the pivotal study.

Read the study: https://bit.ly/4dMIeey